Ibotta (IBTA) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this digital company that offers consumers rewards and rebates would post earnings of $2.02 per share when it actually produced earnings of $2.27, delivering a surprise of 12.38%.Ov ...

TriplePoint Venture Growth (TPVG) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10%. A quarter ago, it was expected that this investment company would post earnings of $0.33 per share when it actually produced earnings of $0.32, delivering a surprise of -3.03%.Over the last four qu ...

Core Viewpoint - IPG Photonics is expected to report a significant decline in earnings and revenues for the first quarter of 2025, primarily due to lower demand in its materials processing business and increased competition, particularly in China [1][3][4]. Financial Expectations - The company anticipates non-GAAP earnings per share between 5 cents and 35 cents, with revenues expected to range from $210 million to $240 million [1]. - The Zacks Consensus Estimate for earnings is set at 21 cents per share, reflecting a 59.62% year-over-year decline [1]. - The revenue estimate stands at $221.18 million, indicating a year-over-year decrease of 12.23% [2]. Demand and Market Conditions - IPG Photonics is facing reduced demand for welding, cutting, and marking applications, which has negatively impacted its financial performance [3]. - In the fourth quarter of 2024, revenues from China fell by 22% year-over-year due to lower demand in industrial markets and competitive pressures [4]. - Economic uncertainty in Europe is also affecting industrial demand and capital investments, leading to sluggish demand from cutting OEM customers [5]. Strategic Initiatives - The company is strategically expanding into new end-markets such as 3D printing, micro-materials processing, electric vehicles, and medical devices, which may provide some offsetting benefits to its revenue [6]. Earnings Surprise History - IPG Photonics has a mixed earnings surprise history, having missed the Zacks Consensus Estimate in two of the last four quarters while beating it in the other two, with an average earnings surprise of 15.97% [2]. Earnings ESP and Zacks Rank - Currently, IPG Photonics has an Earnings ESP of -33.33% and a Zacks Rank of 3 (Hold), indicating lower odds of an earnings beat [7].

Company Overview - Hims & Hers Health, Inc. (HIMS) shares increased by 23% to close at $35.04, with trading volume significantly higher than usual, contrasting with a 3.6% loss over the previous four weeks [1][2] Recent Developments - The surge in Hims & Hers Health's shares is linked to the announcement of a deal to sell Novo Nordisk's weight-loss drug, Wegovy, on its telehealth platform, allowing U.S. customers to access NovoCare Pharmacy through Hims & Hers for $599 per month [2] Financial Performance Expectations - The company is projected to report quarterly earnings of $0.14 per share, reflecting a year-over-year increase of 180%, with revenues expected to reach $537.85 million, a 93.4% rise from the same quarter last year [3] - The consensus EPS estimate for the upcoming quarter has been revised 21.3% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Industry Context - Hims & Hers Health is categorized within the Zacks Medical Info Systems industry, where Health Catalyst (HCAT) is another player, having closed 0.3% higher at $4.07 but showing a -10.4% return over the past month [4]

CG Oncology, Inc. (CGON) shares ended the last trading session 25% higher at $27.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 15.3% loss over the past four weeks.CG Oncology’s shares jumped 25% on Monday after the company unveiled exceptionally durable best-in-disease phase III data for its bladder cancer candidate, cretostimogene grenadenorepvec, at the American Urological Association meeting. In the BOND-0 ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Spotify (SPOT) came out with quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.05 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of -50.66%. A quarter ag ...

Preferred Bank (PFBC) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.33 per share. This compares to earnings of $2.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.29%. A quarter ago, it was expected that this independent commercial bank would post earnings of $2.42 per share when it actually produced earnings of $2.25, delivering a surprise of -7.02%.Over the last four qua ...

Unifi (UFI) shares rallied 14.7% in the last trading session to close at $5.30. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.2% loss over the past four weeks.United Natural stock is rising surrounding optimism about its strategic realignment and continued strength in the natural and organic food segment. Focus on lean management, operational efficiency, and the restructuring of its wholesale business to ...

PJT Partners (PJT) shares soared 8.5% in the last trading session to close at $136.07. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.9% loss over the past four weeks.PJT Partners’ stock experienced a price rise following the Trump administration’s announcement of a temporary halt of 90 days on reciprocal tariffs for most countries. Additionally, PJT excels as a premier, global advisory-focused investment bank, driven by a yo ...

Fidus Investment (FDUS) shares rallied 7.9% in the last trading session to close at $18.69. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 19.6% loss over the past four weeks.Fidus Investment stock surged amid a broad market rally, spurred by President Donald Trump’s announcement of a 90-day tariff pause for non-retaliating nations. The news boosted investor confidence, fueling a sharp uptick in FDUS shares. ...